Focused Ultrasound to Promote Immune Responses for Undifferentiated Pleomorphic Sarcoma

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 23, 2020

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Undifferentiated Pleomorphic Sarcoma
Interventions
DEVICE

ExAblate 2000/2100 Magnetic Resonance-guided Focused Ultrasound (MRgFUS)

The ExAblate 2100 MRgFUS system (InSightec, Inc., Dallas, Texas, USA) is a noninvasive thermal ablation device fully integrated with an MR imaging system and used for the ablation of soft tissue and bone.14-16 The ExAblate combines a focused ultrasound surgery (FUS) delivery system and a conventional diagnostic 3T Magnetic Resonance (MR) scanner. The ExAblate systems provide a real-time therapy planning algorithm, thermal dosimetry, and closed-loop therapy control. The ExAblate transducer device is an integrated component of the MR table

Trial Locations (1)

94143

RECRUITING

University of California, San Francisco, San Francisco

All Listed Sponsors
collaborator

Focused Ultrasound Foundation

OTHER

collaborator

InSightec-TxSonics

INDUSTRY

lead

Matthew Bucknor

OTHER